Mesh Nebulizer (UN204); Mesh Nebulizer (UN205); Mesh Nebulizer (UN209); Mesh Nebulizer (UN210)
Shenzhen Mericonn Technology Co., Ltd. · Decision date Sep 18, 2026
What did the FDA decide?
Shenzhen Mericonn Technology Co., Ltd. received a substantially equivalent (SESE) decision for K254171 on 2026-09-18, a traditional 510(k) reviewed by FDA rather than a third party. The submission, received 12/23/2025, covers four mesh nebulizer models: UN204, UN205, UN209 and UN210. The device falls under classification name Nebulizer (Direct Patient Interface), regulation 868.5630, product code CAF, with anesthesiology as the regulation medical specialty and review panel. SESE means clearance to market, not PMA approval.
The public record does not identify a predicate device, summarize performance testing, or state indications for use, so the basis for equivalence and any model-specific differences among the four variants remain unknown from this page. The listed correspondent is Chonconn Consulting Co., Ltd. No summary document is included in the available material.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Anesthesiology
- Decision date
- Sep 18, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K254171
- Regulatory pathway
- 510(k) premarket notification
- Product code
- CAF
- Decision code
- SESE
- Decision date
- Sep 18, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Nebulizer (Direct Patient Interface).
- Product code
- CAF
- FDA device class
- 2
FDA decision timeline
K254171 received
Application receipt date recorded by FDA.
K254171 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Shenzhen Mericonn Technology Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Shenzhen
Sources and methodology
- Original FDA record: K254171
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records